• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
PPI Long Term Use: Risk of Neurological Adverse Events?质子泵抑制剂的长期使用:存在神经不良事件风险?
Front Neurol. 2019 Jan 8;9:1142. doi: 10.3389/fneur.2018.01142. eCollection 2018.
2
Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities.质子泵抑制药物奥美拉唑、埃索美拉唑、兰索拉唑、泮托拉唑和雷贝拉唑对人细胞色素P450活性的抑制作用比较。
Drug Metab Dispos. 2004 Aug;32(8):821-7. doi: 10.1124/dmd.32.8.821.
3
Proton Pump Inhibitors and Bone Health: An Update Narrative Review.质子泵抑制剂与骨骼健康:更新叙事性综述。
Int J Mol Sci. 2022 Sep 14;23(18):10733. doi: 10.3390/ijms231810733.
4
Evaluation of omeprazole, lansoprazole, pantoprazole, and rabeprazole in the treatment of acid-related diseases.奥美拉唑、兰索拉唑、泮托拉唑和雷贝拉唑治疗酸相关性疾病的疗效评估。
J Am Pharm Assoc (Wash). 2000 Jan-Feb;40(1):52-62; quiz 121-3. doi: 10.1016/s1086-5802(16)31036-1.
5
Evaluation of six proton pump inhibitors as inhibitors of various human cytochromes P450: focus on cytochrome P450 2C19.评价六种质子泵抑制剂对各种人细胞色素 P450 的抑制作用:重点关注细胞色素 P450 2C19。
Drug Metab Dispos. 2012 Sep;40(9):1698-711. doi: 10.1124/dmd.112.045575. Epub 2012 May 30.
6
The use of proton pump inhibitors in children: a comprehensive review.儿童使用质子泵抑制剂:一项全面综述。
Paediatr Drugs. 2003;5(1):25-40. doi: 10.2165/00128072-200305010-00003.
7
Myopathy including polymyositis: a likely class adverse effect of proton pump inhibitors?肌病,包括多发性肌炎:质子泵抑制剂可能的类别不良反应?
Eur J Clin Pharmacol. 2006 Jun;62(6):473-9. doi: 10.1007/s00228-006-0131-1. Epub 2006 Apr 22.
8
Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: evidence from randomized clinical trials.与奥美拉唑、雷尼替丁和安慰剂相比,新型质子泵抑制剂兰索拉唑、雷贝拉唑和泮托拉唑治疗胃食管反流病的愈合率和复发率:来自随机临床试验的证据。
Clin Ther. 2001 Jul;23(7):998-1017. doi: 10.1016/s0149-2918(01)80087-4.
9
Clinical pharmacology of proton pump inhibitors: what the practising physician needs to know.质子泵抑制剂的临床药理学:执业医师需要了解的内容。
Drugs. 2003;63(24):2739-54. doi: 10.2165/00003495-200363240-00004.
10
Qualimetric analysis of proton pump inhibitors in Ukraine.乌克兰质子泵抑制剂的质量分析
Wiad Lek. 2019;72(9 cz 2):1769-1773.

引用本文的文献

1
Pharmacodynamics, pharmacokinetics, interactions with other drugs, toxicity and clinical effectiveness of proton pump inhibitors.质子泵抑制剂的药效学、药代动力学、与其他药物的相互作用、毒性及临床疗效。
Front Pharmacol. 2025 Jul 23;16:1507812. doi: 10.3389/fphar.2025.1507812. eCollection 2025.
2
Causal relationship between proton pump inhibitors and dementia risk: evidence from a Mendelian randomization study.质子泵抑制剂与痴呆风险之间的因果关系:来自孟德尔随机化研究的证据。
Eur Arch Psychiatry Clin Neurosci. 2025 Jun 7. doi: 10.1007/s00406-025-02036-6.
3
Neurological Manifestations Associated With Hypomagnesemia Due to Proton-Pump Inhibitors: A Case Series.质子泵抑制剂所致低镁血症相关的神经学表现:病例系列
Cureus. 2025 Jan 30;17(1):e78229. doi: 10.7759/cureus.78229. eCollection 2025 Jan.
4
Gallic acid alleviates omeprazole-induced depressive behavior and memory impairment.没食子酸可减轻奥美拉唑诱导的抑郁行为和记忆障碍。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Feb 20. doi: 10.1007/s00210-025-03812-w.
5
Effects of the Transcutaneous Electrical Stimulation System on Heartburn, Regurgitation and Esophageal Acid Exposure in GERD Patients-An Uncontrolled Feasibility Study.经皮电刺激系统对胃食管反流病患者烧心、反流及食管酸暴露的影响——一项非对照可行性研究
Neurogastroenterol Motil. 2025 May;37(5):e15002. doi: 10.1111/nmo.15002. Epub 2025 Jan 23.
6
Linking GERD and the Peptide Bombesin: A New Therapeutic Strategy to Modulate Inflammatory, Oxidative Stress and Clinical Biochemistry Parameters.胃食管反流病(GERD)与蛙皮素肽的关联:一种调节炎症、氧化应激及临床生化参数的新治疗策略。
Antioxidants (Basel). 2024 Aug 28;13(9):1043. doi: 10.3390/antiox13091043.
7
Proton Pump Inhibitors and Cognitive Health: Review on Unraveling the Dementia Connection and Co-morbid Risks.质子泵抑制剂与认知健康:揭开痴呆症关联和共病风险之谜的综述。
Curr Alzheimer Res. 2024;20(11):739-757. doi: 10.2174/0115672050289946240223050737.
8
Pharmacokinetics of Antibacterial Agents in the Elderly: The Body of Evidence.老年人抗菌药物的药代动力学:证据主体
Biomedicines. 2023 Jun 4;11(6):1633. doi: 10.3390/biomedicines11061633.
9
Exposure to proton pump inhibitors and risk of diabetes: A systematic review and meta-analysis.质子泵抑制剂的暴露与糖尿病风险:一项系统评价和荟萃分析。
World J Diabetes. 2023 Feb 15;14(2):120-129. doi: 10.4239/wjd.v14.i2.120.
10
Associations between constipation, overeating, and depression: A survey of Chinese oldest-old and centenarians.便秘、暴饮暴食与抑郁症之间的关联:一项针对中国高龄老人和百岁老人的调查。
Heliyon. 2022 Dec 19;8(12):e12432. doi: 10.1016/j.heliyon.2022.e12432. eCollection 2022 Dec.

本文引用的文献

1
Advantages and Disadvantages of Long-term Proton Pump Inhibitor Use.长期使用质子泵抑制剂的利弊
J Neurogastroenterol Motil. 2018 Apr 30;24(2):182-196. doi: 10.5056/jnm18001.
2
Discontinuing Long-Term PPI Therapy: Why, With Whom, and How?停止长期使用质子泵抑制剂(PPI)治疗:为什么、针对谁以及如何停药?
Am J Gastroenterol. 2018 Apr;113(4):519-528. doi: 10.1038/ajg.2018.29. Epub 2018 Mar 20.
3
Use of proton-pump inhibitors is associated with depression: a population-based study.质子泵抑制剂的使用与抑郁症相关:一项基于人群的研究。
Int Psychogeriatr. 2018 Jan;30(1):153-159. doi: 10.1017/S1041610217001715. Epub 2017 Sep 13.
4
Dancing as an Intervention Tool for People with Dementia: A Mini-Review Dancing and Dementia.舞蹈作为痴呆症患者的干预工具:一项小型综述——舞蹈与痴呆症
Curr Alzheimer Res. 2017;14(12):1264-1269. doi: 10.2174/1567205014666170713161422.
5
Proton Pump Inhibitors and Risk of Mild Cognitive Impairment and Dementia.质子泵抑制剂与轻度认知障碍和痴呆症的风险
J Am Geriatr Soc. 2017 Sep;65(9):1969-1974. doi: 10.1111/jgs.14956. Epub 2017 Jun 7.
6
The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association.质子泵抑制剂长期使用的风险和益处:美国胃肠病学会的专家评论和最佳实践建议。
Gastroenterology. 2017 Mar;152(4):706-715. doi: 10.1053/j.gastro.2017.01.031.
7
Risk of dementia from proton pump inhibitor use in Asian population: A nationwide cohort study in Taiwan.亚洲人群使用质子泵抑制剂导致痴呆的风险:台湾一项全国性队列研究
PLoS One. 2017 Feb 15;12(2):e0171006. doi: 10.1371/journal.pone.0171006. eCollection 2017.
8
Dementia, cognitive impairment and proton pump inhibitor therapy: A systematic review.痴呆、认知障碍与质子泵抑制剂治疗:一项系统综述。
J Gastroenterol Hepatol. 2017 Aug;32(8):1426-1435. doi: 10.1111/jgh.13750.
9
Proton pump inhibitors: Risks of long-term use.质子泵抑制剂:长期使用的风险。
J Gastroenterol Hepatol. 2017 Jul;32(7):1295-1302. doi: 10.1111/jgh.13737.
10
25 Years of Proton Pump Inhibitors: A Comprehensive Review.质子泵抑制剂的25年:全面综述
Gut Liver. 2017 Jan 15;11(1):27-37. doi: 10.5009/gnl15502.

质子泵抑制剂的长期使用:存在神经不良事件风险?

PPI Long Term Use: Risk of Neurological Adverse Events?

作者信息

Novotny Michal, Klimova Blanka, Valis Martin

机构信息

Biomedical Research Centrum, University Hospital Hradec Králové, Hradec Králové, Czechia.

Department of Neurology, University Hospital Hradec Kralove, Hradec Králové, Czechia.

出版信息

Front Neurol. 2019 Jan 8;9:1142. doi: 10.3389/fneur.2018.01142. eCollection 2018.

DOI:10.3389/fneur.2018.01142
PMID:30671013
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6331532/
Abstract

The purpose of this review study is to reveal a potential threat of one type of such widely used and freely distributed drugs, which are proton pump inhibitors that might be the cause of the onset of both dementia and depression. The authors performed a literature review of available studies on the research topic describing the adverse effect of proton pum inhibitors (PPIs) (omeprazole, esomeprazole, lansoprazole, dexlansoprazole, rabeprazole, pantoprazole, dexrabeprazole, ilaprazole). For a long time, PPIs were considered to be completely safe drug substances for both short and long-term use. In recent years, there have been a few contradictory studis of absolute safety, especially in patients, who have long been using PPIs. At this time when depression and dementia are rising in the population, this is a very worrying fact that needs to be highlighted, and which needs to be carefully studied and evaluated, ideally trying to prevent it. The findings of most research studies described in this review indicate that there is a direct association between the onset of dementia and depression on one side and the long-term use of PPIs on the other.

摘要

本综述研究的目的是揭示一类广泛使用且免费分发的药物——质子泵抑制剂可能存在的潜在威胁,这类药物可能是导致痴呆和抑郁症发作的原因。作者对有关质子泵抑制剂(PPIs)(奥美拉唑、埃索美拉唑、兰索拉唑、右兰索拉唑、雷贝拉唑、泮托拉唑、右雷贝拉唑、艾普拉唑)不良反应的现有研究进行了文献综述。长期以来,PPIs被认为无论短期还是长期使用都是完全安全的药物。近年来,出现了一些关于其绝对安全性的相互矛盾的研究,尤其是在长期使用PPIs的患者中。在抑郁症和痴呆症在人群中发病率不断上升的这个时期,这是一个非常令人担忧的事实,需要予以强调,并且需要仔细研究和评估,理想情况下要设法预防它。本综述中描述的大多数研究结果表明,一方面痴呆和抑郁症的发作与另一方面长期使用PPIs之间存在直接关联。